Is Mednax Inc (MD) overvalued? · P/E 11, $1.93B cap
Mednax Inc (MD) is a medical care facilities company listed on NYSE.
This page asks whether Mednax Inc (MD) looks expensive on cached numbers — not a short thesis.
No cached income statement for MD, so there is no earnings base to call rich or cheap.
MD currently screens at market cap $1.93B and trailing P/E 11.4. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next MD 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the MD stock page for the full model, not this heading.
Not investment advice.